Abstract
We report the synthesis of a small series of 6"-triazol-1-yl-substituted α-GalCer analogues by late-stage conversion of the 6"-OH to an azide group, copper-catalyzed azide-alkyne cycloaddition and final deprotection. When evaluated for their capacity to induce IL-2 secretion in vitro, all compounds proved equally potent or superior to α-GalCer. The S.A.R suggests that the improved antigenic activity is mainly triggered by the triazole functionalization in se. While the introduction of selected substitutuents at C-4 of this heterocyclic ring is tolerated, this generally fails to further improve antigenicity.
| Original language | English |
|---|---|
| Pages (from-to) | 7149-7154 |
| Number of pages | 6 |
| Journal | Bioorganic & Medicinal Chemistry |
| Volume | 20 |
| Issue number | 24 |
| DOIs | |
| Publication status | Published - 15 Dec 2012 |
Bibliographical note
Copyright © 2012 Elsevier Ltd. All rights reserved.Keywords
- Adjuvants, Immunologic/chemical synthesis
- Animals
- Bone Marrow Cells/drug effects
- Dendritic Cells/drug effects
- Galactosylceramides/chemical synthesis
- Ligands
- Mice
- Natural Killer T-Cells/drug effects
- Triazoles/chemical synthesis